US 7163925
p16 expression constructs and their application in cancer therapy
granted A61KA61K48/00A61K48/005
Quick answer
US patent 7163925 (p16 expression constructs and their application in cancer therapy) held by The Board of Regents of the University of Texas System expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K48/00, A61K48/005